Clinical Trial Update: Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months [Phase 3]

View source ↗

Summary

Phase 3 study evaluating Group ACYW135 meningococcal conjugate vaccine in children aged 12-23 months; the trial is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis
• Meningococcal Disease

Drugs mentioned

• Group ACYW135 Meningococcal Conjugate Vaccine (Meningococcal conjugate vaccine ACYW135)

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Epidemic Meningitis, Meningococcal Vaccines | Phase 3 | Status: NOT_YET_RECRUITING